Raymond Prudo-Chlebosz
Founder en AKARI THERAPEUTICS, PLC .
Fortuna: 6 M $ al 31/07/2023
Perfil
Raymond Prudo-Chlebosz is the founder of Volution Immuno Pharmaceuticals SA (founded in 2008) where he holds the title of Chairman & Chief Executive Officer.
He is also the founder of Akari Therapeutics Plc (founded in 2015) where he holds the title of Executive Chairman.
Additionally, Dr. Prudo-Chlebosz is the founder of Varleigh Immuno Pharmaceuticals Uk Ltd.
(founded in 2007) where he holds the title of Chairman & Chief Executive Officer.
Dr. Prudo-Chlebosz is also the founder of The Doctors Laboratory Ltd.
Currently, he is working as a Director at Health Services Laboratories LLP.
Dr. Prudo-Chlebosz completed his undergraduate degree at the University of London.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
AKARI THERAPEUTICS PLC
23.06% | 01/01/2024 | 2 331 580 600 ( 23.06% ) | 6 M $ | 31/07/2023 |
Cargos activos de Raymond Prudo-Chlebosz
| Empresas | Cargo | Inicio |
|---|---|---|
| AKARI THERAPEUTICS, PLC | Founder | - |
| Varleigh Immuno Pharmaceuticals Uk Ltd. | Chief Executive Officer | 01/01/2007 |
Volution Immuno Pharmaceuticals SA
 Volution Immuno Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Part of Akari Therapeutics Plc, Volution Immuno Pharmaceuticals SA is a Swiss company that develops anti-complement and anti-inflammatory molecules to treat orphan conditions in the autoimmune and inflammatory diseases sectors. The private company is based in Geneva, Switzerland. The company was founded by Raymond Prudo-Chlebosz, who has been the CEO since incorporation. Volution Immuno Pharmaceuticals was acquired by Celsus Therapeutics Plc from RPC Pharma Ltd. on September 18, 2015 for $146.72 million. | Chief Executive Officer | 01/01/2008 |
The Doctors Laboratory Ltd.
 The Doctors Laboratory Ltd. Medical/Nursing ServicesHealth Services Part of Sonic Healthcare Ltd., The Doctors Laboratory Ltd. is a British company that provides pathology services. The private company is based in London, UK. The company was founded in 1987. David Anthony Byrne has been the CEO of the company since 1998. The Doctors Laboratory was acquired by Sonic Healthcare Ltd. on April 11, 2002 for $92.42 million. | Founder | - |
Health Services Laboratories LLP
 Health Services Laboratories LLP Medical/Nursing ServicesHealth Services Health Services Laboratories LLP provides health services. The private company is based in London, UK. and has subsidiaries in United Kingdom. The CEO of the British company is David Anthony Byrne. | Director/Board Member | - |
Formación de Raymond Prudo-Chlebosz.
| University of London | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| AKARI THERAPEUTICS, PLC | Health Technology |
| Empresas privadas | 4 |
|---|---|
The Doctors Laboratory Ltd.
The Doctors Laboratory Ltd. Medical/Nursing ServicesHealth Services Part of Sonic Healthcare Ltd., The Doctors Laboratory Ltd. is a British company that provides pathology services. The private company is based in London, UK. The company was founded in 1987. David Anthony Byrne has been the CEO of the company since 1998. The Doctors Laboratory was acquired by Sonic Healthcare Ltd. on April 11, 2002 for $92.42 million. | Health Services |
Volution Immuno Pharmaceuticals SA
Volution Immuno Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Part of Akari Therapeutics Plc, Volution Immuno Pharmaceuticals SA is a Swiss company that develops anti-complement and anti-inflammatory molecules to treat orphan conditions in the autoimmune and inflammatory diseases sectors. The private company is based in Geneva, Switzerland. The company was founded by Raymond Prudo-Chlebosz, who has been the CEO since incorporation. Volution Immuno Pharmaceuticals was acquired by Celsus Therapeutics Plc from RPC Pharma Ltd. on September 18, 2015 for $146.72 million. | Health Technology |
| Varleigh Immuno Pharmaceuticals Uk Ltd. | |
Health Services Laboratories LLP
Health Services Laboratories LLP Medical/Nursing ServicesHealth Services Health Services Laboratories LLP provides health services. The private company is based in London, UK. and has subsidiaries in United Kingdom. The CEO of the British company is David Anthony Byrne. | Health Services |
- Bolsa de valores
- Insiders
- Raymond Prudo-Chlebosz
